HOWL
Werewolf Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.97
+2.38%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.35x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 1.00x
Liquidity & coverage
- Current ratio
- 2.91x
- Quick ratio
- 2.91x
- Cash ratio
- 2.80x
- Interest coverage
- -5.62x
- EBITDA / interest
- -4.84x
- Working capital
- $15.0M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026